Talaria

chasing medical miracle

About us

Talaria Inc., former Gaea APAC Inc., renewed and reorganized teams with clinical trial specific service on 2024.

History

2024- Current

Talaria renamed

Rename and service as Talaria

Reorganized team for full service Clinical Research

2022-2023

growth of business

involve gorvenment service

Dr. Charles JH Kim, CEO was appointed a reviewer and member of Korea Institute of Drug Safety and Risk Management (KIDS) and Medical Device Consulting Council (MDCC) at Korea Health Industry Development Institute (KHIDI)

2021

establishment of Gaea APAC Inc.

Full service CRO named Gaea APAC Inc. established on May 2021, a proud member of Gaea OU (EU based).

Talaria services

From Laboratory To clinic

Talaria offers a broad range of customized services to support Pharma, biotech and medical device companies to bring new drugs and devices to market approval faster

Consulting

Talaria's consulting service provides strategic analysis to support and conduct best solution in drug and device development

Safety Solutions

Safety and adverse event causality assessment with Talaria's own safety assessment system (Korea Patent 10-2507211)

Clinical Operations

Talaria provides a range of integrated service that cover the feasibility, CTC approval, project management and execution and analysis of clinical trial

Contact Us

Address

2F 21, Tehelan road 128,

Gangnam gu, Seoul, Korea

Opening Hours

Mon - Fri: 9am - 6pm
Saturday / Sunday: Closed
National holiday: Closed

Contact

+82-70 4506 9110
info@talaria.im